Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01532830 · ClinicalTrials.gov registry record · NA
Non-Invasive Neurostimulation For the Relief of Symptoms Associated With Migraine
A NA study of Migraine, sponsored by ElectroCore.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 3
- Study locations
NCT01532830: Completed NA study of Migraine, sponsored by ElectroCore.
NCT01532830 is a NA study of Migraine that has completed, run by ElectroCore. The registered enrollment target is 30 participants, below the 358-participant average among 102 other Migraine trials with a reported enrollment target (92% lower). The trial reports 3 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01532830, a NA study of Migraine, has completed, sponsored by ElectroCore.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 3
- Study locations
Study Summary
The purpose of this pilot study is to assess feasibility and clarify the design of future study(ies) to support marketing approval of the GammaCore™ device for the treatment and/or prevention of migraine symptoms.
Primary Outcome
The primary outcome measure for this study was the assessment of adverse events as unanticipated or anticipated.
Conditions Studied
Interventions
- DEVICE n-VNS
Study Locations (3)
New York
- New York Headache Center - New York
- Montefiore Headache Center - The Bronx
California
- UCSF Headache Center - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2012-02 |
| Est. Completion | 2012-07-25 |
| Phase | NA |
What the finished NCT01532830 record still lists
NCT01532830 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 358-participant average among 102 other Migraine trials with a reported enrollment target (92% lower).
The record links to 1 condition, with Migraine appearing as the primary indexed condition, and to 1 intervention - of which n-VNS is the first listed.
NCT01532830 reports a single indexed study location in New York, California.
Frequently Asked Questions
What is clinical trial NCT01532830 about?
NCT01532830 is a clinical study titled "Non-Invasive Neurostimulation For the Relief of Symptoms Associated With Migraine". The purpose of this pilot study is to assess feasibility and clarify the design of future study(ies) to support marketing approval of the GammaCore™ device for the treatment and/or prevention of migraine symptoms.
What is the current status of trial NCT01532830?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2012-02. Estimated completion is 2012-07-25.
What conditions does trial NCT01532830 study?
This clinical trial studies the following conditions: Migraine.
What interventions are being tested in trial NCT01532830?
The interventions under investigation include: n-VNS (DEVICE).
Who is sponsoring clinical trial NCT01532830?
This trial is sponsored by ElectroCore, which has 6 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01532830 being conducted?
This trial has 3 study locations across California, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Migraine
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01532830's enrollment target sits among peer trials
30 92nd of 102 higher than 8 of 102 other Migraine trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Migraine trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
MMA Embolization for Refractory Chronic Migraine
RECRUITING · NA
-
Stimulation of External Carotid Artery Circulation
RECRUITING · NA
-
Responding With Evidence and Access for Childhood Headaches
RECRUITING · NA
-
Determining the Utility of a Behavioral Intervention in Chronic Migraine
RECRUITING · NA
-
Cocoa Extract for Migraine Trial
RECRUITING · NA
-
Migraine in Adolescents
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia